AGRYLIN Side Effects

6861907-9 | Dehydration, Fall, Loss Of Consciousness, Thrombocytosis, Vertigo
on Jul 08, 2010 Female patient from UNITED STATES , 28 years of age, weighting 158.7 lb, was diagnosed with thrombocytosis, oedema, depression (What is depression?) and was treated with Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, fall (What is fall?), loss of consciousness, thrombocytosis, vertigo. Agrylin dosage: 1.5 Mg, 2x/day:bid. During the same period patient was treated with HYDROCHLOROTHIAZIDE (50 Mg, 1x/day:qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PAMELOR (10 Mg, 1x/day:qd) (View Pamelor Review and Pamelor Label ). Patient was hospitalized.

6830638-3 | Asthenia, Dizziness, Dysuria, Hypoaesthesia, Insomnia, Nervous System Disorder, Platelet Count Increased, Skin Discolouration, Visual Impairment
Patient was taking Agrylin (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), dysuria, hypoaesthesia, insomnia, nervous system disorder, platelet count increased, skin discolouration, visual impairment on Jul 09, 2010 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 237.0 lb, was diagnosed with platelet count increased and. Agrylin dosage: 0.5 Mg 3 Per Day Orally.

6448260-X | Pericarditis
Adverse event was reported on Jul 14, 2009 by a Male patient taking Agrylin (View Usage) (Dosage: 0.5mg, 2x/day; Bid, Oral) . Location: UNITED STATES , 54 years of age, After Agrylin was administered, patient had the following side effects: pericarditis.

6074533-9 |
on Jan 29, 2009 Female patient from KOREA, REPUBLIC OF , 91 years of age, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). . Agrylin dosage: 0.5 Mg, 1x/day:qd.


5959011-7 | Haemorrhagic Stroke
on May 16, 2008 Male patient from UNITED STATES , 48 years of age, weighting 175.0 lb, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). Patient had the following side effects: haemorrhagic stroke. Agrylin dosage: 0.5 Mg, 2x/day:bid, Oral. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized and became disabled.

5959010-5 | Atrioventricular Block, Deep Vein Thrombosis, Pulmonary Embolism
Patient was taking Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: atrioventricular block, deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?) on Mar 11, 2008 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 125.0 lb, was diagnosed with essential thrombocythaemia and. Agrylin dosage: 1.0 To 1.5 Mg Daily, Oral. During the same period patient was treated with HYDREA (View Hydrea Review and Hydrea Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5959003-8 | Anxiety, Epistaxis, Fear, Gingival Bleeding, Headache, Hot Flush, Palpitations, Tachycardia
Adverse event was reported on Aug 01, 2008 by a Female patient taking Agrylin (View Usage) (Dosage: 0.5 Mg, 1x/day:qd, Oral) . Location: UNITED STATES , 53 years of age, weighting 117.9 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), epistaxis, fear, gingival bleeding, headache (What is headache?), hot flush, palpitations, tachycardia.

5678766-2 | Haemorrhage Intracranial, Intraventricular Haemorrhage
on Mar 07, 2008 Female patient from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF , 37 years of age, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). Patient had the following side effects: haemorrhage intracranial, intraventricular haemorrhage. Agrylin dosage: 1 Mg, 2x/day:bid, Oral; 1.5 Mg, 2x/day:bid, Oral; 1 Mg, 2x/day:bid, Oral. During the same period patient was treated with ASTRIX (ACETYLSALICYLIC ACID) (View Astrix (acetylsalicylic Acid) Review and Astrix (acetylsalicylic Acid) Label ).

5565841-6 | Bile Duct Cancer
on Dec 11, 2007 Male patient from CANADA , 59 years of age, was treated with Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: bile duct cancer. Agrylin dosage: 4 Mg Daily, Oral. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NORVASC (View Norvasc Review and Norvasc Label ).

5358544-4 | Cerebrovascular Accident
Patient was taking Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident on Jun 13, 2007 from UNITED STATES Additional patient health information: Male patient , 48 years of age, weighting 185.0 lb, was diagnosed with essential thrombocythaemia and. Agrylin dosage: . Patient was hospitalized.

5331671-3 | Colitis Ulcerative, Crohn's Disease, Rectal Haemorrhage, Weight Decreased
Adverse event was reported on May 08, 2007 by a Female patient taking Agrylin (View Usage) (Dosage: 0.5 Mg, Oral) was diagnosed with platelet count increased and. Location: UNITED STATES , 78 years of age, Patient had the following side effects: colitis ulcerative, crohn's disease (What is crohn's disease?), rectal haemorrhage, weight decreased. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), QUINARETIC (HYDROCHLOROTHIAZIDE, QUINAPRIL HYDROCHLORIDE) (View Quinaretic (hydrochlorothiazide, Quinapril Hydrochloride) Review and Quinaretic (hydrochlorothiazide, Quinapril Hydrochloride) Label ), COSOPT (View Cosopt Review and Cosopt Label ). Patient was hospitalized.

5325310-5 | Nephritic Syndrome, Nephritis
on Apr 25, 2007 Female patient from SINGAPORE , 42 years of age, was treated with Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: nephritic syndrome, nephritis. Agrylin dosage: .

5306149-3 | White Blood Cell Count Increased
on Apr 20, 2007 Female patient from UNITED STATES , 62 years of age, weighting 115.0 lb, was diagnosed with blood disorder and was treated with Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count increased. Agrylin dosage: 0.5 Mg 2 Po Bid.

5257084-0 | Platelet Count Decreased
Patient was taking Agrylin (View Usage). Patient had the following side effects: platelet count decreased on Feb 16, 2007 from UNITED STATES Additional patient health information: Male patient , 51 years of age, weighting 186.1 lb, was diagnosed with polycythaemia vera and. Agrylin dosage: 0.5 Mg, 4x/day:qid, Oral. During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ).

5167307-4 | Platelet Count Increased
Adverse event was reported on Nov 21, 2006 by a Female patient taking Agrylin (View Usage) (Dosage: See Image) was diagnosed with thrombocythaemia and. Location: UNITED STATES , 68 years of age, weighting 177.0 lb, After Agrylin was administered, patient had the following side effects: platelet count increased. During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ).

5086068-0 | Acute Leukaemia, Anaemia
on Aug 09, 2006 Female patient from SINGAPORE , 60 years of age, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia, anaemia. Agrylin dosage: Oral. During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), INTERFERON (INTERFERON) (View Interferon (interferon) Review and Interferon (interferon) Label ).

5085884-9 | Cardiac Failure Congestive, Cardiac Valve Disease, International Normalised Ratio Increased, Platelet Count Decreased
on Aug 10, 2006 Male patient from UNITED STATES , 74 years of age, weighting 162.0 lb, was diagnosed with myeloproliferative disorder and was treated with Agrylin (View Usage). Patient had the following side effects: cardiac failure congestive, cardiac valve disease, international normalised ratio increased, platelet count decreased. Agrylin dosage: 0.5 Mg To 1 Mg Daily, Unk, Oral - See Image. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), PROSCAR (View Proscar Review and Proscar Label ), COREG (View Coreg Review and Coreg Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5080820-3 | Abdominal Discomfort, Abdominal Distension, Abnormal Behaviour, Aphasia, Blood Potassium Decreased, Cerebral Infarction, Cerebrovascular Accident, Cognitive Disorder, Computerised Tomogram Abnormal
Patient was taking Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: abdominal discomfort, abdominal distension, abnormal behaviour, aphasia (What is aphasia?), blood potassium decreased, cerebral infarction, cerebrovascular accident, cognitive disorder, computerised tomogram abnormal on Jul 28, 2006 from UNITED STATES Additional patient health information: Male patient , 46 years of age, was diagnosed with essential thrombocythaemia and. Agrylin dosage: See Image. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized and became disabled.

5080816-1 | Aneurysm, Cerebrovascular Accident, Fatigue, Intracranial Aneurysm, Transient Ischaemic Attack, Vasculitis Cerebral
Adverse event was reported on Jul 28, 2006 by a Female patient taking Agrylin (View Usage) (Dosage: See Image) was diagnosed with essential thrombocythaemia and. Location: UNITED STATES , 67 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: aneurysm (What is aneurysm?), cerebrovascular accident, fatigue, intracranial aneurysm, transient ischaemic attack, vasculitis cerebral. During the same period patient was treated with NEXIUM /01479302/ (ESOMEPRAZOLE MAGNESIUM) (View Nexium /01479302/ (esomeprazole Magnesium) Review and Nexium /01479302/ (esomeprazole Magnesium) Label ), IRON (IRON) (View Iron (iron) Review and Iron (iron) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VITAMIN C + E (ASCORBIC ACID, TOCOPHEROL) (View Vitamin C + E (ascorbic Acid, Tocopherol) Review and Vitamin C + E (ascorbic Acid, Tocopherol) Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized and became disabled.

5066438-7 | Left Ventricular Failure
on Nov 17, 2005 Female patient from AUSTRALIA , 46 years of age, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). Patient had the following side effects: left ventricular failure. Agrylin dosage: 0.5 Mg, 4x/day; Qid, Oral. Patient was hospitalized.

5036601-X | Nephritis Interstitial, Renal Failure Acute
on Jun 01, 2006 Male patient from CANADA , 86 years of age, was treated with Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: nephritis interstitial, renal failure acute. Agrylin dosage: 1 Mg 2x/day Bid Oral. During the same period patient was treated with ALTACE (View Altace Review and Altace Label ), LASIX (View Lasix Review and Lasix Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ZANTAC (View Zantac Review and Zantac Label ).

5031478-0 | Cardiac Failure, Pulmonary Hypertension
Patient was taking Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, pulmonary hypertension (What is pulmonary hypertension?) on Jan 06, 2006 from UNITED STATES Additional patient health information: Male patient , 34 years of age, was diagnosed with essential thrombocythaemia and. Agrylin dosage: .

5031245-8 | Left Ventricular Failure
Adverse event was reported on Nov 17, 2005 by a Female patient taking Agrylin (View Usage) (Dosage: 0.5 Mg,4x/day:qid,oral) was diagnosed with essential thrombocythaemia and. Location: AUSTRALIA , 46 years of age, Patient had the following side effects: left ventricular failure. Patient was hospitalized.

4998296-0 | Heart Valve Insufficiency
on Apr 25, 2006 Male patient from UNITED STATES , 74 years of age, weighting 162.0 lb, was diagnosed with myeloproliferative disorder and was treated with Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: heart valve insufficiency. Agrylin dosage: 0.5 Mg To 1 Mg Daily, Unk. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), PROSCAR (View Proscar Review and Proscar Label ), COREG (View Coreg Review and Coreg Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

4950868-5 | Thrombocythaemia
on Mar 07, 2006 Male patient from LEBANON , weighting 207.2 lb, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocythaemia. Agrylin dosage: See Image. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4943507-0 | Electrocardiogram Qt Prolonged, Torsade De Pointes, Ventricular Tachycardia
Patient was taking Agrylin (View Usage). Patient had the following side effects: electrocardiogram qt prolonged, torsade de pointes, ventricular tachycardia on Feb 23, 2006 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 151.9 lb, was diagnosed with myeloproliferative disorder and. Agrylin dosage: 0.5 Mg, 3x/day:tid. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), METOPROLOL (METOPROLOL) (View Metoprolol (metoprolol) Review and Metoprolol (metoprolol) Label ), ZOCOR (View Zocor Review and Zocor Label ), ASPIRIN /00002701)/(ACETYLSALICYLIC ACID) (View Aspirin /00002701)/(acetylsalicylic Acid) Review and Aspirin /00002701)/(acetylsalicylic Acid) Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), IMMUNOGLOBULIN (IMMUNOGLOBULIN) (View Immunoglobulin (immunoglobulin) Review and Immunoglobulin (immunoglobulin) Label ), DECADRON /00016001/(DEXAMETHASONE) (View Decadron /00016001/(dexamethasone) Review and Decadron /00016001/(dexamethasone) Label ), LOVENOX /00889602/(HEPARIN FRACTION, SODIUM SALT) (View Lovenox /00889602/(heparin-fraction, Sodium Salt) Review and Lovenox /00889602/(heparin-fraction, Sodium Salt) Label ). Patient was hospitalized.

4927578-3 | Asthenia, Malignant Neoplasm Progression, Memory Impairment, Migraine Without Aura, Platelet Count Decreased, Tremor, Upper Respiratory Tract Infection
Adverse event was reported on Feb 16, 2006 by a Female patient taking Agrylin (View Usage) (Dosage: 0.5 Mg, Tiw) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 65 years of age, weighting 359.4 lb, After Agrylin was administered, patient had the following side effects: asthenia, malignant neoplasm progression, memory impairment, migraine without aura, platelet count decreased, tremor, upper respiratory tract infection. During the same period patient was treated with CLONAZEPAM (2 Mg, Qhs) (View Clonazepam Review and Clonazepam Label ), DEPAKOTE (250 Mg, Bid) (View Depakote Review and Depakote Label ), GLEEVEC (400 Mg, Bid) (View Gleevec Review and Gleevec Label ), POTASSIUM CHLORIDE (20 Meq, Qd) (View Potassium Chloride Review and Potassium Chloride Label ), FOSAMAX ONCE WEEKLY (70 Mg, Qw) (View Fosamax Once Weekly Review and Fosamax Once Weekly Label ). Patient was hospitalized.

4919802-8 | Thrombocythaemia
on Feb 13, 2006 Male patient from LEBANON , weighting 207.2 lb, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocythaemia. Agrylin dosage: 0.5 Mg Capsule. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4883128-1 | Atrial Fibrillation, Cardiac Arrest, Cardiac Failure Congestive, Ventricular Fibrillation
on Jan 17, 2006 Male patient from UNITED STATES , 65 years of age, weighting 154.0 lb, was diagnosed with myeloproliferative disorder, thrombocythaemia and was treated with Agrylin (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac arrest (What is cardiac arrest?), cardiac failure congestive, ventricular fibrillation. Agrylin dosage: 1 Mg 3 Tabs Daily Po. Patient was hospitalized and became disabled.

4869148-1 | Cardiac Failure Congestive, Ejection Fraction Decreased
Patient was taking Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: cardiac failure congestive, ejection fraction decreased on Dec 28, 2005 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 124.0 lb, was diagnosed with myeloproliferative disorder, thrombocythaemia and. Agrylin dosage: 2 Mg Am And 1 Mg Pm Po. During the same period patient was treated with HYDREA (View Hydrea Review and Hydrea Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), PROTONIX (View Protonix Review and Protonix Label ), COMBIVENT (View Combivent Review and Combivent Label ), LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYTRIN (View Hytrin Review and Hytrin Label ). Patient was hospitalized.

4861039-5 | Acute Coronary Syndrome, Coronary Artery Disease, Ejection Fraction Decreased, Electrocardiogram T Wave Inversion
Adverse event was reported on Dec 08, 2005 by a Male patient taking Agrylin (View Usage) (Dosage: See Image) was diagnosed with platelet count increased and. Location: UNITED STATES , 66 years of age, weighting 170.0 lb, Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, coronary artery disease (What is coronary artery disease?), ejection fraction decreased, electrocardiogram t wave inversion. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4815198-0 | Balance Disorder, Extrasystoles, Fall, Heart Rate Increased, Hyperhidrosis, Off Label Use, Palpitations
on Oct 21, 2005 Female patient from UNITED STATES , 46 years of age, weighting 140.0 lb, was diagnosed with raynaud's phenomenon and was treated with Agrylin (View Usage). Patient had the following side effects: balance disorder, extrasystoles, fall (What is fall?), heart rate increased, hyperhidrosis, off label use, palpitations. Agrylin dosage: See Image. During the same period patient was treated with LOVASTATIN (View Lovastatin Review and Lovastatin Label ), VICODIN (View Vicodin Review and Vicodin Label ).

4788047-7 | Myelofibrosis
on Jan 10, 2005 Female patient from DENMARK , 47 years of age, was diagnosed with thrombocythaemia and was treated with Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: myelofibrosis. Agrylin dosage: 1.5 Mg, 2x/day: Bid, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

4788046-5 | Myelofibrosis
Patient was taking Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: myelofibrosis on Jan 10, 2005 from DENMARK Additional patient health information: Male patient , 65 years of age, was diagnosed with thrombocythaemia and. Agrylin dosage: 0.5 Mg , 3x/day: Tid, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

4786098-X | Platelet Count Increased
Adverse event was reported on Sep 22, 2005 by a Male patient taking Agrylin (View Usage) (Dosage: 0.5mg, 4x/day;qid) . Location: LEBANON , weighting 220.5 lb, Patient had the following side effects: platelet count increased. During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ).

4761024-8 | Angina Pectoris, Coronary Artery Occlusion, Endothelial Dysfunction, Oedema Peripheral, Therapeutic Response Unexpected
on Aug 19, 2005 Female patient from UNITED STATES , 41 years of age, weighting 112.0 lb, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: angina pectoris, coronary artery occlusion, endothelial dysfunction, oedema peripheral, therapeutic response unexpected. Agrylin dosage: 0.5 Mg, 3x/day; Tid, Oral.

4761020-0 | Amnesia, Contusion, Leukaemia, Oedema Peripheral, Platelet Count Increased, Transient Ischaemic Attack
on Aug 18, 2005 Female patient from UNITED STATES , 86 years of age, was diagnosed with thrombocythaemia and was treated with Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, contusion, leukaemia, oedema peripheral, platelet count increased, transient ischaemic attack. Agrylin dosage: 0.5 Mg, 4x/day; Qid, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), PLAVIX (View Plavix Review and Plavix Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PROTONIX (View Protonix Review and Protonix Label ), DITROPAN (View Ditropan Review and Ditropan Label ).

4691960-2 | Asthenia, Autoimmune Disorder, Cardiolipin Antibody Positive, Chest Pain, Eye Irritation, Eye Pain, Glaucoma, Hypotrichosis, Nausea
Patient was taking Agrylin (View Usage). Patient had the following side effects: asthenia, autoimmune disorder, cardiolipin antibody positive, chest pain (What is chest pain?), eye irritation, eye pain, glaucoma (What is glaucoma?), hypotrichosis, nausea (What is nausea?) on Jun 01, 2005 from Additional patient health information: Female patient , 59 years of age, weighting 209.9 lb, was diagnosed with essential thrombocythaemia and. Agrylin dosage: See Iimage. During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), AMILORIDE HCL W/HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE, AMILORIDE HY (View Amiloride Hcl W/hydrochlorothiazide (hydrochlorothiazide, Amiloride Hy Review and Amiloride Hcl W/hydrochlorothiazide (hydrochlorothiazide, Amiloride Hy Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), VITAMIN B COMPLEX (THIAMINE HYDROCHLORIDE, RIBOFLAVIN, PYRIDOXINE HYD (View Vitamin B Complex (thiamine Hydrochloride, Riboflavin, Pyridoxine Hyd Review and Vitamin B Complex (thiamine Hydrochloride, Riboflavin, Pyridoxine Hyd Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

4674731-2 | Anaemia, Blood Creatinine Increased, Blood Urea Increased, Cardiac Failure Congestive, Diabetic Nephropathy, Renal Failure
Adverse event was reported on Apr 08, 2005 by a Female patient taking Agrylin (View Usage) (Dosage: 0.5 Mg, Bid) was diagnosed with chronic myeloid leukaemia and. Location: , 74 years of age, After Agrylin was administered, patient had the following side effects: anaemia, blood creatinine increased, blood urea increased, cardiac failure congestive, diabetic nephropathy, renal failure. During the same period patient was treated with ALLOPURINOL (100 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), HYDREA (500 Mg, Bid) (View Hydrea Review and Hydrea Label ), GLEEVEC (200 Mg, Qd) (View Gleevec Review and Gleevec Label ).

4630826-0 | Anaemia, Cardiac Fibrillation, Platelet Count Increased, Therapeutic Response Decreased
on Mar 31, 2005 Male patient from , 74 years of age, weighting 160.0 lb, was diagnosed with polycythaemia vera and was treated with Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, cardiac fibrillation, platelet count increased, therapeutic response decreased. Agrylin dosage: One Capsule Daily; Increased On 1/28/05 To Two Capsules Daily;dose Raised To 3 Capsules Twice A Day. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ). Patient was hospitalized.

4616249-9 | Abdominal Discomfort, Abdominal Distension, Abnormal Behaviour, Aphasia, Asthenia, Blood Potassium Decreased, Bone Marrow Depression, Brain Mass, Brain Neoplasm
on Mar 14, 2005 Male patient from , 46 years of age, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). Patient had the following side effects: abdominal discomfort, abdominal distension, abnormal behaviour, aphasia (What is aphasia?), asthenia, blood potassium decreased, bone marrow depression, brain mass, brain neoplasm. Agrylin dosage: See Image. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOPRAZOLE (PANTOPRAZOLE) (View Pantoprazole (pantoprazole) Review and Pantoprazole (pantoprazole) Label ). Patient was hospitalized.

4616245-1 | Asthenia, Chest Pain, Hypotrichosis, Nausea, Optic Neuritis, Palpitations, Pancreatitis Acute, Photophobia
Patient was taking Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: asthenia, chest pain (What is chest pain?), hypotrichosis, nausea (What is nausea?), optic neuritis, palpitations, pancreatitis acute, photophobia on Mar 07, 2005 from Additional patient health information: Female patient , 59 years of age, weighting 209.9 lb, was diagnosed with essential thrombocythaemia and. Agrylin dosage: See Image. During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), AMILORIDE HCL W/HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE, AMILORIDE HY (View Amiloride Hcl W/hydrochlorothiazide (hydrochlorothiazide, Amiloride Hy Review and Amiloride Hcl W/hydrochlorothiazide (hydrochlorothiazide, Amiloride Hy Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), VITAMIN B COMPLEX (THIAMINE HYDROCHLORIDE, RIBOFLAVIN, PYRIDOXINE HYDR (View Vitamin B Complex (thiamine Hydrochloride, Riboflavin, Pyridoxine Hydr Review and Vitamin B Complex (thiamine Hydrochloride, Riboflavin, Pyridoxine Hydr Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

4615243-1 | Acute Myeloid Leukaemia, Disease Progression, Essential Thrombocythaemia
Adverse event was reported on Jan 10, 2005 by a Male patient taking Agrylin (View Usage) (Dosage: 0.5 Mg, 1x/day: Qd, Oral) was diagnosed with essential thrombocythaemia and. Location: , 43 years of age, Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, disease progression, essential thrombocythaemia. During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), MYLERAN (View Myleran Review and Myleran Label ).

4612302-4 | Blood Creatine Increased, Blood Potassium Increased, Renal Amyloidosis, Renal Arteriosclerosis, Renal Interstitial Fibrosis, Renal Tubular Disorder
on Mar 02, 2005 Male patient from , 60 years of age, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). Patient had the following side effects: blood creatine increased, blood potassium increased, renal amyloidosis, renal arteriosclerosis, renal interstitial fibrosis, renal tubular disorder. Agrylin dosage: See Image. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), VITAMIN B12 (View Vitamin B12 Review and Vitamin B12 Label ), MULTIVITAMINS (ASCORBIC ACID/ERGOCALCIFEROL/FOLIC ACID/NICOTINAMIDE/PA (View Multivitamins (ascorbic Acid/ergocalciferol/folic Acid/nicotinamide/pa Review and Multivitamins (ascorbic Acid/ergocalciferol/folic Acid/nicotinamide/pa Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), IRON PREPARATIONS (View Iron Preparations Review and Iron Preparations Label ).

4599826-3 | Abortion Spontaneous, Pregnancy
on Feb 17, 2005 Female patient from , 40 years of age, was diagnosed with essential thrombocythaemia and was treated with Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?). Agrylin dosage: . During the same period patient was treated with DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4599582-9 | Abdominal Pain, Asthenia, Chest Pain, Dizziness, Headache, Hypothyroidism, Musculoskeletal Stiffness, Myalgia, Nausea
Patient was taking Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), asthenia, chest pain (What is chest pain?), dizziness (What is dizziness?), headache (What is headache?), hypothyroidism, musculoskeletal stiffness, myalgia, nausea (What is nausea?) on Feb 15, 2005 from Additional patient health information: Female patient , 70 years of age, was diagnosed with polycythaemia and. Agrylin dosage: 0.5 Mg, 2x/day:bid. During the same period patient was treated with REQUIP (View Requip Review and Requip Label ), LEVODOPA CARBIDOPA (LEVODOPRA, CARBIDOPA) (View Levodopa-carbidopa (levodopra, Carbidopa) Review and Levodopa-carbidopa (levodopra, Carbidopa) Label ), AMANTADINE (AMANTADINE) (View Amantadine (amantadine) Review and Amantadine (amantadine) Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

4573616-X | Circulatory Collapse, Orthostatic Hypotension, Palpitations, Tachycardia
Adverse event was reported on Jan 21, 2005 by a Female patient taking Agrylin (View Usage) (Dosage: 1.5 Mg, 2x/day: Bid) was diagnosed with thrombocythaemia and. Location: , 41 years of age, weighting 143.3 lb, Patient had the following side effects: circulatory collapse, orthostatic hypotension, palpitations, tachycardia. During the same period patient was treated with LITALIR (HYDROXYCARBAMIDE) (View Litalir (hydroxycarbamide) Review and Litalir (hydroxycarbamide) Label ).

4564624-3 | Food Intolerance, Gastrointestinal Infection, Haemodialysis, Nausea, Pyrexia, Tubulointerstitial Nephritis
on Jun 01, 2004 Female patient from , 75 years of age, was diagnosed with polycythaemia vera and was treated with Agrylin (View Usage). After Agrylin was administered, patient had the following side effects: food intolerance, gastrointestinal infection, haemodialysis, nausea (What is nausea?), pyrexia, tubulointerstitial nephritis. Agrylin dosage: See Image, Oral. During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ). Patient was hospitalized.

4561162-9 | Angiopathy, Cataract, Retinal Disorder, Vitrectomy
on Jan 06, 2005 Male patient from , 69 years of age, weighting 170.0 lb, was diagnosed with platelet count increased and was treated with Agrylin (View Usage). Patient experienced the following unwanted or unexpected effects: angiopathy, cataract (What is cataract?), retinal disorder (What is retinal disorder?), vitrectomy. Agrylin dosage: See Image. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), FUROSEMIDE (FUROSEMIDE) (View Furosemide (furosemide) Review and Furosemide (furosemide) Label ), NADOLOL (View Nadolol Review and Nadolol Label ), BUFFERIN /USA/ (ACETYSALICYLIC ACID, MAGNESIUM CARBONATE, ALUMINIUM G (View Bufferin /usa/ (acetysalicylic Acid, Magnesium Carbonate, Aluminium G Review and Bufferin /usa/ (acetysalicylic Acid, Magnesium Carbonate, Aluminium G Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ).

4559244-0 | Asthenia, Failure To Thrive, Neutropenia
Patient was taking Agrylin (View Usage). Patient had the following side effects: asthenia, failure to thrive, neutropenia on Jan 21, 2005 from Additional patient health information: Female patient , 83 years of age, weighting 132.3 lb, was diagnosed with polycythaemia and. Agrylin dosage: Oral. During the same period patient was treated with AGGRENOX (1 Tab Bid Oral) (View Aggrenox Review and Aggrenox Label ). Patient was hospitalized.